Clinical Trial Update: Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer [NA]

View source ↗

Summary

This clinical trial compares standard SBRT dosing to radiobiologically-guided SBRT dosing for liver cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Hepatocellular Carcinoma, Liver Metastases | NA | Status: RECRUITING